www.fdanews.com/articles/159882-japans-eisai-to-launch-breast-cancer-drug-in-india

Japan’s Eisai to Launch Breast Cancer Drug in India

November 6, 2013

Japanese drugmaker Eisai is planning to launch its anti-cancer drug Eribulin, also known as Halaven, in India.
The Economic Times